Generics in France

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $350	41 Pages	MarketLine	December, 2024	MTLN19647714

Best Price Guarantee
Price	from $350
Length	41 Pages
Publisher	MarketLine
Published Date	December, 2024
SKU	MTLN19647714

Generics in France

Summary

Generics in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
The French generics market recorded revenues of $4.5 billion in 2023, representing a compound annual growth rate (CAGR) of 5.5% between 2018 and 2023.
Market consumption volume increased with a CAGR of 1.5% between 2018 and 2023, to reach a total of 37.6% of total pharma volume in 2023.
According to GlobalData, in 2023, the French generics market grew by 5.7% annually. The growth is attributed to the country’s mounting aging population. According to the United States Census Bureau, in 2023, the population aged 65 years and above in France reached 14.7 million, up 2.7% over 2022.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in France
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the France generics market by value in 2023?
What will be the size of the France generics market in 2028?
What factors are affecting the strength of competition in the France generics market?
How has the market performed over the last five years?
Who are the top competitors in France's generics market?

1 Executive Summary: 1.1. Market value; 1.2. Market value forecast; 1.3. Market volume; 1.4. Market volume forecast; 1.5. Geography segmentation; 1.6. Market rivalry; 1.7. Competitive landscape
2 Market Overview: 2.1. Market definition; 2.2. Market analysis
3 Market Data: 3.1. Market value; 3.2. Market volume
4 Market Segmentation: 4.1. Geography segmentation
5 Market Outlook: 5.1. Market value forecast; 5.2. Market volume forecast
6 Five Forces Analysis: 6.1. Summary; 6.2. Buyer power; 6.3. Supplier power; 6.4. New entrants; 6.5. Threat of substitutes; 6.6. Degree of rivalry
7 Competitive Landscape: 7.1. Who are the leading players?; 7.2. What are the strengths of the leading players?; 7.3. Has the government recently implemented any initiatives aimed at boosting the market?
8 Company Profiles: 8.1. Teva Pharmaceutical Industries Ltd; 8.2. Novartis AG; 8.3. Sanofi; 8.4. Les Laboratoires Servier SAS
9 Macroeconomic Indicators: 9.1. Country data
10 Appendix: 10.1. Methodology; 10.2. Industry associations; 10.3. Related MarketLine research; 10.4. About MarketLine
List of Tables: Table 1: France generics market value: $ million, 2018-23; Table 2: France generics market volume: % of total pharma volume, 2018-23; Table 3: France generics market geography segmentation: $ million, 2023; Table 4: France generics market value forecast: $ million, 2023-28; Table 5: France generics market volume forecast: % of total pharma volume, 2023-28; Table 6: Teva Pharmaceutical Industries Ltd: Key Facts; Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios; Table 8: Teva Pharmaceutical Industries Ltd: Key Employees; Table 9: Novartis AG: Key Facts; Table 10: Novartis AG: Annual Financial Ratios; Table 11: Novartis AG: Key Employees; Table 12: Sanofi: Key Facts; Table 13: Sanofi: Annual Financial Ratios; Table 14: Sanofi: Key Employees; Table 15: Les Laboratoires Servier SAS: Key Facts; Table 16: Les Laboratoires Servier SAS: Key Employees; Table 17: France Size of Population (million), 2019-23; Table 18: France Real GDP (Constant 2010 Prices, $ Billion) 2019-23; Table 19: France GDP (Current Prices, $ Billion), 2019-23; Table 20: France Inflation, 2019-23; Table 21: France Consumer Price Index (Absolute), 2019-23; Table 22: France Exchange Rate, 2018-23
List of Figures: Figure 1: France generics market value: $ million, 2018-23; Figure 2: France generics market volume: % of total pharma volume, 2018-23; Figure 3: France generics market geography segmentation: % share, by value, 2023; Figure 4: France generics market value forecast: $ million, 2023-28; Figure 5: France generics market volume forecast: % of total pharma volume, 2023-28; Figure 6: Forces driving competition in the generics market in France, 2023; Figure 7: Drivers of buyer power in the generics market in France, 2023; Figure 8: Drivers of supplier power in the generics market in France, 2023; Figure 9: Factors influencing the likelihood of new entrants in the generics market in France, 2023; Figure 10: Factors influencing the threat of substitutes in the generics market in France, 2023; Figure 11: Drivers of degree of rivalry in the generics market in France, 2023